TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26618796

Group type: EXPERIMENTAL
Intervention: Mobile psychosocial intervention
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standard MMT
Number of subjects: 25
Study: 24739445

Group type: EXPERIMENTAL
Intervention: Atazanavir/ritonavir (ATV/r)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Lopinavir/ritonavir (LPV/r)
Number of subjects: 224
Study: 23171536

Group type: EXPERIMENTAL
Intervention: internet-based guided self-help program (GSH-I)
Number of subjects: 175

Group type: COMPARATOR
Intervention: cognitive-behavioral therapy (CBT)
Number of subjects: 175
Study: 19903773

Group type: EXPERIMENTAL
Intervention: Classrooms cleaned daily with a quaternary ammonium wipe
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control classrooms (not cleaned daily)
Number of subjects: 6
Study: 17712763

Group type: EXPERIMENTAL
Intervention: Directly administered antiretroviral therapy (DAART)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Self-administered therapy
Number of subjects: 141
Study: 15774540

Group type: EXPERIMENTAL
Intervention: Elective single embryo transfer
Number of subjects: 661

Group type: COMPARATOR
Intervention: Double embryo transfer
Number of subjects: 661
Study: 12198867

Group type: EXPERIMENTAL
Intervention: Fluoridated elastomeric ligatures
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Non-fluoridated elastomeric ligatures
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control specimen (no elastomeric ligatures)
Number of subjects: 14
Study: 9807603

Group type: EXPERIMENTAL
Intervention: Normal saline 16 ml/kg plus intravenous ephedrine boluses (0.1 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Normal saline 8 ml/kg plus intramuscular depot ephedrine (0.5 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Haemaccel 8 ml/kg plus metaraminol infusion
Number of subjects: 60
Study: 7695411

Group type: EXPERIMENTAL
Intervention: Video-assisted thoracic surgery
Number of subjects: 44

Group type: COMPARATOR
Intervention: Lateral thoracotomy
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 44
Study: 2566248

Group type: EXPERIMENTAL
Intervention: Clobazam 40 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 263938

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine sulfate 5 mg/70 kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine sulfate 10 mg/70 kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine sulfate 15 mg/70 kg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Dextroamphetamine sulfate 0 mg/70 kg (placebo)
Number of subjects: 12
Study: 31004129

Group type: EXPERIMENTAL
Intervention: WASH interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IYCF interventions
Number of subjects: 0
Study: 31703722

Group type: EXPERIMENTAL
Intervention: SMS technology
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enhanced WBOTs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study: 28352657

Group type: EXPERIMENTAL
Intervention: Erlotinib (EGFR inhibitor)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Dasatinib (Src inhibitor)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Combination of erlotinib and dasatinib
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 26475403

Group type: EXPERIMENTAL
Intervention: 100 ng/mL cutoff
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 200 ng/mL cutoff
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 500 ng/mL cutoff
Number of subjects: 121
Study: 25098502

Group type: EXPERIMENTAL
Intervention: TXT-2-Quit (TXT) intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Daily non‐smoking related text messages (control condition)
Number of subjects: 60
Study: 21330043

Group type: EXPERIMENTAL
Intervention: CBRN-PPE
Number of subjects: 48

Group type: COMPARATOR
Intervention: Normal clothes
Number of subjects: 48
Study: 18759847

Group type: EXPERIMENTAL
Intervention: New method for estimating the complier average causal effect (CACE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Assumed nonignorable missing-data model
Number of subjects: 0
Study: 17602732

Group type: EXPERIMENTAL
Intervention: HPV16/18 vaccine
Number of subjects: 9258

Group type: COMPARATOR
Intervention: Hepatitis A vaccine (Control)
Number of subjects: 9258
Study: 14991337

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A treatment
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 10971315

Group type: EXPERIMENTAL
Intervention: ORAL
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: MDI
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: MDI + C
Number of subjects: 7

Group type: COMPARATOR
Intervention: ORAL + C
Number of subjects: 7
Study: 9338882

Group type: EXPERIMENTAL
Intervention: Multichannel surface electromyographic (EMG) signals during elbow flexion and extension
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spectrogram representation of low-frequency EMG spectra
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Polar representation of low-frequency spectra of multichannel EMG
Number of subjects: 0
Study: 8408368

Group type: COMPARATOR
Intervention: Behavioural management plus relaxation placebo
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Combined behavioural-cognitive self-management approach
Number of subjects: 27
Study: 3775141

Group type: EXPERIMENTAL
Intervention: Stress management program for treatment of hypertension (10 weeks duration)
Number of subjects: 21
Study: 31675086

Group type: EXPERIMENTAL
Intervention: Universal screening using the Patient Health Questionnaire‐9 (PHQ‐9) from September through December of the academic year.
Number of subjects: 9650

Group type: COMPARATOR
Intervention: Targeted screening based on observable behavior (current process).
Number of subjects: 9650
Study: 27523435

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate (FF) or fluticasone propionate
Number of subjects: 2672

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2672
Study: 24523054

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT) administration
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo spray
Number of subjects: 16
Study: 22928579

Group type: EXPERIMENTAL
Intervention: Proactive telephone counselling
Number of subjects: 1562

Group type: EXPERIMENTAL
Intervention: Waiting more than an hour to smoke after waking and intention to quit within 30 days at baseline
Number of subjects: 1562
Study: 20818967

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19104769

Group type: EXPERIMENTAL
Intervention: Salsalate (3 g/day, n = 28)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo (n = 26)
Number of subjects: 54
Study: 17001068

Group type: EXPERIMENTAL
Intervention: Bortezomib 1.3 mg/m² administered on days 1, 4, 8, and 11 of a 21-day cycle, for up to 17 cycles.
Number of subjects: 155
Study: 14557435

Group type: EXPERIMENTAL
Intervention: Metformin (500 mg twice daily for 3 months, then 1000 mg twice daily for 3 months)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Ethinyl estradiol (35 micro g)‐cyproterone acetate (2 mg) oral contraceptive pills
Number of subjects: 52
Study: 10389531

Group type: EXPERIMENTAL
Intervention: Target pressure < or = 90 mmHg
Number of subjects: 18790

Group type: EXPERIMENTAL
Intervention: Target pressure < or = 85 mmHg
Number of subjects: 18790

Group type: EXPERIMENTAL
Intervention: Target pressure < or = 80 mmHg
Number of subjects: 18790

Group type: EXPERIMENTAL
Intervention: 75 mg aspirin 1 dd
Number of subjects: 18790
Study: 8965185

Group type: COMPARATOR
Intervention: Placebo infusion (Group 1, n = 10)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo bolus infusions (Group 2, n = 8)
Number of subjects: 18
Study: 1324462

Group type: EXPERIMENTAL
Intervention: Lactobacillus GG fermented milk product
Number of subjects: 39

Group type: COMPARATOR
Intervention: Pasteurized yogurt (placebo group)
Number of subjects: 39
Study: 6407812

Group type: EXPERIMENTAL
Intervention: i.v. verapamil, 5‐10 mg/h for two days
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no specific treatment)
Number of subjects: 29
Study: 31478125

Group type: EXPERIMENTAL
Intervention: High monocyte count (HMC) group (monocytes ≥ 0.53 × 10^9/L)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Low monocyte count (LMC) group (monocytes < 0.53 × 10^9/L)
Number of subjects: 206
Study: 31277091

Group type: EXPERIMENTAL
Intervention: TrueCPR device
Number of subjects: 94
Study: 28558697

Group type: EXPERIMENTAL
Intervention: Cognitive aid provided
Number of subjects: 20

Group type: COMPARATOR
Intervention: No cognitive aid
Number of subjects: 20
Study: 26934986

Group type: EXPERIMENTAL
Intervention: Cerebrolysin
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 24530146

Group type: EXPERIMENTAL
Intervention: Self-administered microneedle patches
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Microneedle patches (snap device)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo microneedle patches
Number of subjects: 91
Study: 22153707

Group type: EXPERIMENTAL
Intervention: HA-5FU group
Number of subjects: 50

Group type: COMPARATOR
Intervention: 5FU group
Number of subjects: 50
Study: 20980359

Group type: EXPERIMENTAL
Intervention: Low-flux haemodialysis
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High-flux haemodialysis
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Haemodiafiltration
Number of subjects: 18

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 18
Study: 18055489

Group type: EXPERIMENTAL
Intervention: Betadine eye drops
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Erythromycin eye drops
Number of subjects: 330

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 330
Study: 16229236

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 12011795

Group type: EXPERIMENTAL
Intervention: Bright light therapy (5000 lux from 6-8 a.m.) and imipramine 150 mg/day
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Bright light therapy (5000 lux from 6-8 a.m.) and imipramine-like placebo
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Dim red light (500 lux from 6-8 a.m.) and imipramine 150 mg/day
Number of subjects: 34
Study: 10470708

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin
Number of subjects: 14

Group type: COMPARATOR
Intervention: Intravenous cyclophosphamide
Number of subjects: 14
Study: 8547196

Group type: EXPERIMENTAL
Intervention: Intensive surveillance including physician visits, bone scans, liver sonograms, chest X‐rays, and laboratory tests at predefined intervals (655 patients)
Number of subjects: 1320

Group type: COMPARATOR
Intervention: Control regimen with clinically motivated tests (665 patients)
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: Health-related quality of life measurements at 6, 12, 24 and 60 months
Number of subjects: 1320
Study: 1298620

Group type: EXPERIMENTAL
Intervention: Sodium supplementation (3 mMol/kg/day sodium chloride for 6 weeks)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (fed only on mothers' milk)
Number of subjects: 66
Study: 6731757

Group type: EXPERIMENTAL
Intervention: Electrostimulation anesthesia (ESA)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Nitrous oxide-enflurane anesthesia
Number of subjects: 22
Study: 30121697

Group type: EXPERIMENTAL
Intervention: Bromocriptine 2.5 mg for 1 week (n=10)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Bromocriptine 5 mg for 2 weeks followed by 2.5 mg for 6 weeks (n=14)
Number of subjects: 40
Study: 29351658

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure monitoring (frequent home blood pressure monitoring and 24-hour ambulatory blood pressure monitoring)
Number of subjects: 1048

Group type: COMPARATOR
Intervention: Conventional blood pressure monitoring (usual ad hoc blood pressure monitoring by office measurements)
Number of subjects: 1048

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure monitoring
Number of subjects: 1048

Group type: COMPARATOR
Intervention: Conventional blood pressure monitoring
Number of subjects: 1048
Study: 25956933

Group type: EXPERIMENTAL
Intervention: New C-arm imaging platform
Number of subjects: 78
Study: 23116881

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg/day
Number of subjects: 313

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 313
Study: 21767413

Group type: EXPERIMENTAL
Intervention: Standardized scanning rehabilitation program (Neuro Vision Technology (NVT) program) of 7 weeks at 3 times per week
Number of subjects: 0

Group type: COMPARATOR
Intervention: Individualized therapy recommended by clinicians
Number of subjects: 0
Study: 19339140

Group type: COMPARATOR
Intervention: Counseling Only
Number of subjects: 204

Group type: COMPARATOR
Intervention: Counseling + Transfer
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Counseling + Methadone
Number of subjects: 204
Study: 16780595

Group type: EXPERIMENTAL
Intervention: 2-mirror gonioscope (Goldmann)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: 4-mirror gonioscope (Sussman)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Auto-Keratometer
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Topography-based Sim K
Number of subjects: 99

Group type: COMPARATOR
Intervention: Comparison of both gonioscopes
Number of subjects: 99
Study: 15267009

Group type: EXPERIMENTAL
Intervention: High-flux dialyzers (8 different brands)
Number of subjects: 3
Study: 11775412

Group type: EXPERIMENTAL
Intervention: High risk subjects identified and treated during the study.
Number of subjects: 1200
Study: 9467276

Group type: EXPERIMENTAL
Intervention: Serum prolactin concentrations
Number of subjects: 0
Study: 1581948

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine integrated with EPI
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Trial groups (two different immunization schedules)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180
Study: 4003628

Group type: EXPERIMENTAL
Intervention: Self report
Number of subjects: 0

Group type: COMPARATOR
Intervention: Proxy report
Number of subjects: 0
Study: 31738492

Group type: EXPERIMENTAL
Intervention: Ablative fractional laser with laser-assisted delivery of bimatoprost
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Non-ablative fractional laser
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fractional ablative laser
Number of subjects: 40
Study: 28701365

Group type: EXPERIMENTAL
Intervention: McKenzie Method of Mechanical Diagnosis and Therapy (MDT)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study: 24632743

Group type: EXPERIMENTAL
Intervention: Face cognition speed training
Number of subjects: 99
Study: 20842406

Group type: EXPERIMENTAL
Intervention: Free base tablet formulation (180 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Bisphosphate salt capsule formulation (240 mg; 183 mg free base equivalent)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Bisphosphate salt capsule formulation (200 mg) administered 3 times a week
Number of subjects: 12
Study: 20836725

Group type: EXPERIMENTAL
Intervention: PF-592379 (200 mg oral dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PF-592379
Number of subjects: 0
Study: 17210880

Group type: EXPERIMENTAL
Intervention: RCT participants (n = 953)
Number of subjects: 8469

Group type: COMPARATOR
Intervention: Eligible nonenrolled patients (n = 4669)
Number of subjects: 8469

Group type: COMPARATOR
Intervention: Ineligible patients (n = 2847)
Number of subjects: 8469
Study: 16095449

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 microg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 60
Study: 12390376

Group type: EXPERIMENTAL
Intervention: Stapled haemorrhoidopexy
Number of subjects: 55

Group type: COMPARATOR
Intervention: Conventional diathermy haemorrhoidectomy
Number of subjects: 55
Study: 10089261

Group type: EXPERIMENTAL
Intervention: Intradialytic exercise program (cycling or walking, with optional stretching/light weights)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Intradialytic exercise program
Number of subjects: 26
Study: 7762464

Group type: EXPERIMENTAL
Intervention: Inversion detection in older subjects
Number of subjects: 36

Group type: COMPARATOR
Intervention: Inversion detection in younger subjects
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Eversion detection in older subjects
Number of subjects: 36

Group type: COMPARATOR
Intervention: Eversion detection in younger subjects
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Unipedal stance
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Velocity increase from 2 to 200 degrees/s
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Threshold for sensing rotation in weight-bearing ankle
Number of subjects: 36
Study: 1964728

Group type: EXPERIMENTAL
Intervention: 15 mg of beta-carotene daily for four weeks
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 120 mg of beta-carotene daily for four weeks
Number of subjects: 15
Study: 26516

Group type: EXPERIMENTAL
Intervention: 10 mg mequitazine daily for 14 days
Number of subjects: 48

Group type: COMPARATOR
Intervention: 24 mg brompheniramine daily for 14 days
Number of subjects: 48
Study: 31954132

Group type: EXPERIMENTAL
Intervention: Cold snare piecemeal endoscopic mucosal resection (CSP‐EMR)
Number of subjects: 186
Study: 31162128

Group type: EXPERIMENTAL
Intervention: Telemedicine intervention via SMS text messages (every other week or weekly)
Number of subjects: 348

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 348
Study: 28679686

Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 984

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 984
Study: 25841624

Group type: EXPERIMENTAL
Intervention: Charged Particle Therapy (CPT)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Iodine-125 Plaque Therapy
Number of subjects: 184
Study: 23712578

Group type: EXPERIMENTAL
Intervention: Miniarc single-incision sling
Number of subjects: 71

Group type: COMPARATOR
Intervention: Advantage retropubic mid-urethral sling
Number of subjects: 71
Study: 21112655

Group type: EXPERIMENTAL
Intervention: PEG-IFN
Number of subjects: 200

Group type: COMPARATOR
Intervention: ETV
Number of subjects: 200
Study: 19951446

Group type: EXPERIMENTAL
Intervention: Supervised resistance/aerobic exercise
Number of subjects: 370

Group type: COMPARATOR
Intervention: Printed material comprising general physical activity recommendations
Number of subjects: 370
Study: 17309740

Group type: EXPERIMENTAL
Intervention: 0.9% saline
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: 2.5% NaOCl
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: 3% H(2)O(2)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: 17% EDTA
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Ultracaine D‐S
Number of subjects: 140

Group type: COMPARATOR
Intervention: absence of an irrigating solution (control)
Number of subjects: 140
Study: 15829447

Group type: EXPERIMENTAL
Intervention: Home-based (HB) physical activity program, 3 times per week for 6 months
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control (CTL) condition, usual pattern of physical activity
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Home-based (HB) physical activity program
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control (CTL) condition
Number of subjects: 37
Study: 11560298

Group type: EXPERIMENTAL
Intervention: Lactobacillus GG, 20 x 10(9) CFU/d
Number of subjects: 302

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 302
Study: 9692126

Group type: EXPERIMENTAL
Intervention: 100 micrograms of salbutamol inhaled from the MDPI
Number of subjects: 26

Group type: COMPARATOR
Intervention: 100 micrograms of salbutamol inhaled from the pMDI + S
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo from the MDPI
Number of subjects: 26
Study: 8147091

Group type: EXPERIMENTAL
Intervention: R32Tox‐A vaccine
Number of subjects: 199

Group type: COMPARATOR
Intervention: Control vaccine
Number of subjects: 199
Study: 3062536

Group type: EXPERIMENTAL
Intervention: Apraclonidine hydrochloride (ALO 2145)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study: 30478457

Group type: EXPERIMENTAL
Intervention: Macintosh laryngoscope
Number of subjects: 108
Study: 28145964

Group type: EXPERIMENTAL
Intervention: Laparoscopic-assisted rectus sheath block (LRSB) with 10 mL of 0.25% levobupivacaine at 4 sites after umbilical wound closure
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Laparoscopic-assisted rectus sheath block (LRSB)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group with conventional postoperative pain management
Number of subjects: 38
Study: 26340010

Group type: EXPERIMENTAL
Intervention: Immediate loading
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional loading (Control)
Number of subjects: 36
Study: 24601127

Group type: EXPERIMENTAL
Intervention: VUS-guided peripheral intravenous catheter insertion
Number of subjects: 335

Group type: COMPARATOR
Intervention: Traditional puncture guided by clinical assessment (Control Group)
Number of subjects: 335
Study: 20004877

Group type: EXPERIMENTAL
Intervention: Proclear 1-Day
Number of subjects: 41

Group type: COMPARATOR
Intervention: Focus Dailies with AquaRelease
Number of subjects: 41
Study: 18437130

Group type: EXPERIMENTAL
Intervention: Nebivolol 5 mg daily for 4 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Atenolol 50 mg daily for 4 weeks
Number of subjects: 40
Study: 16169315

Group type: EXPERIMENTAL
Intervention: Tirofiban (group 1)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Clopidogrel plus provisional abciximab (group 2)
Number of subjects: 300
Study: 12576946

Group type: EXPERIMENTAL
Intervention: MAB-T88 (300 mg intravenous infusion over 30 mins)
Number of subjects: 826

Group type: COMPARATOR
Intervention: Placebo (albumin)
Number of subjects: 826
Study: 10593636

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High baseline daily stress
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High baseline hostility
Number of subjects: 80